Daybue 200 mg/mL oral solution Images
Generic Name: trofinetide
This medication has been identified as Daybue 200 mg/mL oral solution. It is supplied by Acadia Pharmaceuticals Inc.
Daybue is used in the treatment of Rett Syndrome and belongs to the drug class miscellaneous central nervous system agents. Daybue 200 mg/mL oral solution is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Daybue
- Generic Name
- trofinetide
- Strength
- 200 mg/mL oral solution
- Availability
- Prescription only
- Drug Class
- Miscellaneous central nervous system agents
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Acadia Pharmaceuticals Inc.
- National Drug Code (NDC)
- 63090-0660
See also:
Addyi
Addyi (flibanserin) is used to treat hypoactive sexual desire disorder (HSDD) in certain women ...
Ampyra
Ampyra (dalfampridine) is used to improve walking in patients with multiple sclerosis. Includes ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Bridion
Bridion is used for reversal of neuromuscular blockade, reversal of nondepolarizing muscle relaxants
Hydergine
Hydergine is used for alzheimer's disease, arteriosclerotic dementia, dementia
Inapsine
Inapsine is used for nausea/vomiting, nausea/vomiting, postoperative
Kisunla
Kisunla (donanemab) is used to treat Alzheimer’s disease to help slow down the decline in memory, t ...
Leqembi
Leqembi (lecanemab) is used to treat Alzheimer’s disease to help slow the progression of dementia s ...
More about Daybue (trofinetide)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous central nervous system agents
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.